跳至主要内容
临床试验/IRCT138901293744N1
IRCT138901293744N1已完成2 期

Assessment of Pentoxifylline effect in reduction of serum C-Reactive Protein (CRP) level in hemodialysis patients in Booali Sina's hemodialysis center

Qazvin University of Medical Sciences0 个研究点目标入组 66 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • hemodialysis patients with ESRD (?End Stage Renal Disease) in Booali Sina's hemodialysis center. Exclusion criteria: history of Hypersensitivity to Pentoxifylline, Xanthines (eg, caffeine, theophylline), or any component of the formulation; recent cerebral and/or retinal hemorrhage; inflamatory situations (such as connective tissue Dis., diabetic foot and other vascular problems, active infections, malignancies, recent traumas, wounds and surgeries); and take any anti-inflamatory drugs in 2 months prior to trial.

排除标准

  • 未提供

研究者

相似试验